www.Send2Press.com Neotrope®
Press Release Writing and News Distribution, US newswire services
Send2Press® - Press Release Writing, Distribution and Media Relations since 1983  
Affordable Newswire Services and Targeted News Distribution, prbuzz marketing and mass media distribution, press release writing
BUSINESS WEB WIRE PR NEWSWIRE SERVICES NEWS CHANNELS
Press Release Distribution
PR Services
Business News and Entertainment Headlines - Drugs and Pharmaceuticals

Drugs and Pharmaceuticals News
Drugs and Pharmaceuticals News Stories from Send2Press Newswire

 Site Search:     

Thursday, July 24, 2008

 

Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for The Treatment of Osteosarcoma
Tue, 08 Jul 2008, 14:42:48 EDTEdited by Carly Zander
SAN MARINO, Calif., July 8 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of osteosarcoma. Based on several criteria, including the rarity, seriousness, and current lack of effective therapies for metastatic osteosarcoma, as well as the scientific and medicinal merit of Rexin-G, the granting of Orphan Drug Status by the FDA validates the unique clinical development strategy.

Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G
Thu, 29 May 2008, 13:19:21 EDTEdited by Carly Zander
SAN MARINO, Calif., May 29 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies announced today the results of an on-going Phase I/II study of Rexin-G for metastatic bone and soft tissue sarcoma (J Clin Oncol 26: 14509, 2008). Rexin-G is the first and so far only targeted gene therapy vector that has been tested in the clinic (Nature Reviews/Genetics 2007).

CYNACON / OCuSOFT(R) Announces OCuSOFT(R) Lid Scrub(TM) PLUS Now Available in CVS Pharmacies
Wed, 28 May 2008, 01:05:25 EDTEdited by Liisa Sullivan
RICHMOND, Texas, May 28 (SEND2PRESS NEWSWIRE) -- CYNACON / OCuSOFT(R) (OCuSOFT(R), Inc.), a company specializing in ophthalmic research, development and supply to ophthalmologists and optometrists, is pleased to announce that as a convenience to all patients, OCuSOFT(R) Lid Scrub(TM) Plus is now available in CVS pharmacies, nationwide.

Targeted Gene Delivery Signals Cancer Vaccination in Vivo
Tue, 27 May 2008, 11:40:00 EDTEdited by Debra Tone
SAN MARINO, Calif., May 27 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies announced today that the results of a Phase I Feasibility Study of sequential targeted gene delivery-using Rexin-G followed by Reximmune-C-for cancer vaccination will be presented at the ASCO meetings in Chicago on June 1, 2008 (J Clin Oncol 26:3077, 2008). Rexin-G and Reximmune-C are pathotropic (disease-seeking) nanoparticles bearing a cytocidal cyclin G1 gene and a granulocyte-macrophage colony stimulating factor (GM-CSF) gene, respectively.

TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
Thu, 22 May 2008, 12:46:02 EDTEdited by Debra Tone
SAN MARINO, Calif., May 22 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies announced today the promising results of an on-going United States-based Phase I/II study of Rexin-G for metastatic breast cancer that is refractory to conventional chemotherapy (J Clin Oncol 26:14509, 2008). This clinical trial employed intra-patient dose-escalations of Rexin-G given i.v. two to three times a week for 4 weeks, with doses ranging from 2 x 10e11 cfu to 6 x 10e11 cfu per week.

ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity without Toxicity in Metastatic Pancreatic Cancer
Mon, 19 May 2008, 07:10:36 EDTEdited by Carly Zander
SAN MARINO, Calif., May 19 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies announced today the results of an on-going Phase I/II study of Rexin-G for metastatic pancreatic cancer (Chawla et al., ASCO meeting, 2008). Continuing on with the planned dose-escalations of Rexin-G which began in 2005 using lower doses of Rexin-G in a Phase I safety study (Molecular Therapy, 2008), the current Phase I/II study employed higher dose-escalations of Rexin-G given i.v. two to three times a week for 4 weeks.

Eularis to Address Marketing Return at Japanese Pharmaceutical Marketing Excellence Conference
Mon, 12 May 2008, 01:25:00 EDTEdited by Debra Tone
TOKYO and LONDON, U.K., May 12 (SEND2PRESS NEWSWIRE) -- Dr. Andree Bates, president of the New York and London-based pharmaceutical analytics company Eularis, will be delivering a presentation on how to tell if you are making the wrong marketing decision. The Pharmaceutical Marketing Excellence conference takes place in Tokyo, Japan.

Eularis to Address Making the Right Research Decision for ROI
Mon, 21 Apr 2008, 10:49:23 EDTEdited by Carly Zander
NEW YORK, N.Y. and LONDON, U.K., April 21 (SEND2PRESS NEWSWIRE) -- Dr. Andree Bates, president of the pharmaceutical analytics company Eularis, will be delivering a presentation on Making the Right Research Decision for ROI - The Link Between Research and Decisions on Bottom Line Return, at 3rd Annual Pharmaceutical Market Research Summit.

Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy with No Dose Limiting Toxicity in Metastatic Pancreatic Cancer
Mon, 21 Apr 2008, 08:30:26 EDTEdited by Carly Zander
SAN MARINO, Calif., April 21 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation announced today that Interim Analysis of an on-going Phase I/II study of Rexin-G for pancreatic cancer confirmed Rexin-G's anti-tumor activity with no major toxicity in patients with metastatic chemotherapy-resistant pancreatic cancer.

Cypress Systems, Inc. Launches Cancer Prevention Health Campaign Using SelenoExcell(R)
Tue, 15 Apr 2008, 01:03:26 EDTEdited by Carly Zander
FRESNO, Calif., April 15 (SEND2PRESS NEWSWIRE) -- Chairman and CEO, Paul Willis stated, 'Just like his previous career at a large agribusiness company, Dr. Mark E. Whitacre has risen fast at Cypress Systems, Inc, last month being named the company's chief operating officer and president of operations.' Now Cypress and Whitacre are focusing their energy on an aggressive cancer prevention campaign in order to get Americans-and people around the world-to consume a special type of selenium known as SelenoExcell(R).

Mark Whitacre, Ph.D. Promoted at Cypress Systems, Inc. and a Warner Bros. Movie to be Filmed About Him
Tue, 25 Mar 2008, 02:00:11 EDTEdited by Carly Zander
FRESNO, Calif., March 25 (SEND2PRESS NEWSWIRE) -- Cypress Systems, Inc., a Fresno CA based biotechnology company, announced that it has promoted Mark E. Whitacre, Ph.D. to become the company's Chief Operating Officer (COO) and President of Operations. Dr. Whitacre joined the executive management team in December 2006 as President of Technology and Business Development for the new east coast office.

Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
Tue, 25 Mar 2008, 01:05:29 EDTEdited by Carly Zander
SAN MARINO, Calif., March 25 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation announced today the issue of U.S. Patent No. 7,347,998 for Targeted Gene Delivery in vivo. This patent provides additional intellectual property protection for the platform of highly advanced biotechnologies embodied in the company's leading anti-cancer agent, Rexin-G.

Eularis Exposes Hidden Barriers to Patient Adherence with New Pharmaceutical Industry Report
Wed, 12 Mar 2008, 13:16:18 EDTEdited by Debra Tone
NEW YORK, N.Y. and LONDON, U.K., March 12 (SEND2PRESS NEWSWIRE) -- Costing the global pharmaceutical industry an estimated $30 billion per year and causing an estimated 125,000 deaths per year in the United States, patient non-adherence is a looming issue in the healthcare industry. Eularis has responded to this problem with a new report, available today, titled, 'Ensuring Profitable Patient Adherence Programs.'

MEDIA ALERT: Eularis to Address Marketing Return at Measuring Marketing ROI in Pharma Conference in London
Mon, 10 Mar 2008, 12:50:35 EDTEdited by Debra Tone
NEW YORK, N.Y. and LONDON, U.K., March 10 (SEND2PRESS NEWSWIRE) -- Dr. Andree Bates, president of the pharmaceutical analytics company Eularis, will be delivering a presentation on meeting the challenges of measuring ROI within the changing dynamics of the pharma industry.

Losing Weight But Still Have Belly Bulge?
Thu, 06 Mar 2008, 12:32:05 EDTEdited by Carly Zander
SALT LAKE CITY, Utah, March 6 (SEND2PRESS NEWSWIRE) -- The same diet that's helping you lose weight might actually be causing you to retain figure-destroying belly fat. That 's because dieting is stressful. You worry about what to eat... when to eat... how much to eat. All that worry leads to 'diet stress,' according to the experts at the Carter-Reed Company(TM), the makers of America's most popular 'Belly Fat' pill, Relacore(R)

Myo-Med, Tom Brady and STG Media Corp. Team Up to Jump Start Myo-Med's 2008 Advertising Campaign
Wed, 05 Mar 2008, 10:28:02 EDTEdited by Carly Zander
TEMPE, Ariz., March 5 (SEND2PRESS NEWSWIRE) -- Superbowl quarterback, Tom Brady has agreed to be the face of Myo-Med, for the launch of their 2008 media campaign. BioForce, the makers of Myo-Med, recently appointed STG Media Corp. as their agency of record to assist them in creating brand awareness among athletes and arthritis sufferers nationwide.

Recent Studies Suggest Popular 'Diet Pill' Reduces Acne Breakouts
Fri, 15 Feb 2008, 09:55:36 EDTEdited by Carly Zander
NEW YORK, N.Y. - Feb. 15 (SEND2PRESS NEWSWIRE) -- As crazy as it sounds, recent studies conducted at Stanford and Wake Forest Schools of Medicine suggest there's a connection between stubborn stress-related belly bulge, unsightly acne flare-ups and the so-called 'Belly Fat' pill, Relacore(R)... and that link is stress. Well, now it seems that stress also increases both the frequency and the severity of acne breakouts. While this may be terrible news for millions of us who seem to be stressed-out even on the best of days, it turns out to be great news for the Carter-Reed Company.

deverus, Inc. Partners with eScreen Inc. to Offer First and Only Instrumented Instant Drug Testing Device to Clients
Fri, 04 Jan 2008, 11:28:55 EDTEdited by Carly Zander
AUSTIN, Texas - Jan. 4 (SEND2PRESS NEWSWIRE) -- deverus, Inc., the leader in background screening technology, recently announced a partnership with eScreen Inc., a company known for its innovative drug screening technology. After comparing different providers, deverus found that no one could match the selection and quality of products that eScreen had to offer. Through eScreen, deverus will now provide clients with technology that creates a web-based system that delivers faster drug test results and paperless transactions.

Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
Tue, 18 Dec 2007, 10:58:09 EDTEdited by Debra Tone
SAN MARINO, Calif. - Dec. 18 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation announced today their appreciation of the accomplishments of their contemporaries in 2007, a truly remarkable year in terms of biomedical research, scholarship, and gonzo journalism. It was a year in which a definitive meeting entitled 'In Vivo Barriers to Gene Delivery' was held at the prestigious Cold Spring Harbor Laboratory, where Nobel laureate James Watson presides, or shall we say presided.

ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G, a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
Mon, 17 Dec 2007, 14:46:32 EDTEdited by Carly Zander
SAN MARINO, Calif. - Dec. 17 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation announced today that the company has received a Certificate of Product Registration for Rexin-G(R) from the Philippine Bureau of Food and Drugs (BFAD), enabling the commercialization of its lead product as a safe and effective treatment for a broad spectrum of intractable cancers. Developed as a tumor-targeted anticancer agent, that actively seeks out and destroys metastatic cancers, Rexin-G exhibits unprecedented single-agent efficacy.

New Report Examines Pharmaceutical Sales Force Effectiveness
Tue, 20 Nov 2007, 16:18:41 EDTEdited by Carly Zander
LONDON, U.K. and NEW YORK, N.Y. - Nov. 20 (SEND2PRESS NEWSWIRE) -- With the ever-increasing pressure to ensure maximum return on investment, sales force effectiveness is becoming a high priority in the global pharmaceutical industry. Reports have shown that while sales forces represent the largest spend in pharma sales and marketing, return on this investment has declined sharply in recent years.

FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A.
Mon, 05 Nov 2007, 07:37:06 EDTEdited by Carly Zander
SAN MARINO, Calif. - Nov. 5 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation announced today that the company has taken a major step toward the commercialization of its lead product with the opening of a Phase II Registration Protocol using Rexin-G for osteosarcoma in the United States. Following the accelerated approval of Rexin-G for the treatment of all solid tumors by the Bureau of Food and Drugs in the Philippines.

OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research
Thu, 11 Oct 2007, 20:58:00 EDTEdited by Liisa Sullivan
RICHMOND, Texas - Oct. 11 (SEND2PRESS NEWSWIRE) -- OCuSOFT Inc., producer of the popular ocular-lid hygiene products, OCuSOFT(R) Lid Scrub(TM) and OCuSOFT(R) Lid Scrub(TM) PLUS, is responding to a recent advertisement released by Advanced Vision Research (AVR) that was found to be misleading.

Ophthalmic Research and Development Company Launches Adjunctive Eyelid Therapy and Hygiene Product
Mon, 06 Aug 2007, 19:46:00 EDTEdited by Liisa Sullivan
RICHMOND, Texas - Aug. 6 (SEND2PRESS NEWSWIRE) -- CYNACON /OCuSOFT(R) (OCuSOFT, Inc.) specializes in ophthalmic research, development and supply to ophthalmologists and optometrists. They are excited to announce a new and innovative prescription-only ALODOX(R) Convenience Kit for adjunctive eyelid therapy and hygiene.

U.S. Pharmaceuticals Spend $8 Billion Annually in R&D Conducted Overseas - New Clintelligence(R) Alignment Module Advances Global Management
Tue, 12 Jun 2007, 18:00:00 EDTEdited by Chris Simmons
KENILWORTH, N.J. - June 12 (SEND2PRESS NEWSWIRE) -- 3C Company, Inc., a leading provider of Business Performance Optimization (BPO) solutions to the Life Sciences Industry, announces today the release of a new module to its highly successful Clintelligence(R) Business Intelligence Solution.

News from the Battlefield of Metastatic Cancer: Epeius Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G) from the Stone of Chemistry and Physics
Mon, 04 Jun 2007, 17:38:00 EDTEdited by Carly Zander
SAN MARINO, Calif. - June 4 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation today announced the publication of a historic landmark in medical oncology and a definitive benchmark in the emerging field of cancer gene therapy. The first clinical report of its kind, Le Morte du Tumour - published in the June issue of the International Journal of Oncology, Vol.30, pp. 1297-1307 - documents the histologic features of tumor destruction observed in chemo-resistant cancers.

Epeius Biotechnologies Reaches Out to American Cancer Patients, Gains FDA Approval for Two New Clinical Trials Using Rexin-G(TM) for Breast Cancer and Sarcoma
Mon, 04 Jun 2007, 15:53:00 EDTEdited by Chris Simmons
SAN MARINO, Calif. - June 4 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation announced today the expansion of ongoing clinical trials using Rexin-G(TM) in the United States to include breast cancer and all types of sarcomas that have failed standard chemotherapy. Following on the heels of their landmark clinical trials in the United States and abroad, the US FDA granted Orphan Drug Status for Rexin-G.

Drug Development Costs Exceed $802 Million: Global Pharmas Use Clintelligence to Do Something About It
Wed, 02 May 2007, 19:00:00 EDTEdited by Chris Simmons
KENILWORTH, N.J. - May 2, 2007 (SEND2PRESS NEWSWIRE) -- 3C Company, Inc., a leading provider of Business Performance Optimization (BPO) solutions to the Life Sciences Industry, announced today that it has aligned with yet another Global Pharmaceutical Firm to implement Clintelligence - 3C Company's Business Intelligence Solution for strategic and tactical oversight of their Research and Development portfolio.

Tired... Distressed... Unhappy? All Natural 'Feel Good' Pill Strikes a Chord with Millions of Women
Thu, 26 Apr 2007, 20:44:00 EDTEdited by Carly Zander
SALT LAKE CITY, Utah - Apr. 26 (SEND2PRESS NEWSWIRE) -- This provocative opening line from a television commercial for a 'mood elevating' pill has really struck a nerve. If the overwhelming response to the Libutol(TM) ad is any indication, it seems American women are more tired, distressed and unhappy than most experts (and women themselves) are willing to admit. That's the logical conclusion drawn from the phenomenal reaction women are having to Libutol, 'The Little Yellow Pill That Makes Life Better' from Blackett Pharmacal(TM).

Updated: Japanese Study Confirms Safety and Efficacy of Intravenous Rexin-G as Treatment for Diverse Metastatic Cancers
Wed, 06 Dec 2006, 20:35:00 EDTEdited by Christopher Simmons
SAN MARINO, Calif. and TOKYO, Japan - Dec. 6, 2006 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies announced today the first results of an independent study conducted in Japan that further documents the safety and efficacy of intravenous Rexin-G(TM) in a broad spectrum of patients with chemo-resistant metastatic cancer. Although the study began in October, only two months ago, the initial reports are both encouraging and noteworthy.

Japanese Study Confirms Safety and Efficacy of Intravenous Rexin-G(TM) as Treatment for Diverse Metastatic Cancers
Wed, 06 Dec 2006, 13:45:00 EDTEdited by Christopher Simmons
SAN MARINO, Calif. and TOKYO, Japan - Dec. 6 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies announced today the first results of an independent study conducted in Japan that further documents the safety and efficacy of intravenous Rexin-G in a broad spectrum of patients with chemo-resistant metastatic cancer. Although the study began in October, only two months ago, the initial reports are both encouraging and noteworthy. The lead investigator of the Japanese study, Dr. Takaki Imamura, will be presenting his findings and clinical recommendations at a special medical conference to be held in Tokyo, Japan, on December 16, 2006.

Epeius Biotechnologies Affirms Leadership Role in The Development of Genetic Medicine
Wed, 11 Oct 2006, 16:18:00 EDTEdited by Christopher Simmons
SAN MARINO, Calif. - Oct. 11 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation today announced that Dr. Frederick Hall, President and CEO of Epeius Biotechnologies, has accepted an invitation to speak at the upcoming Global Pharmaceutical Research & Development Summit held on Oct. 24 at 4:10 p.m. (PT) in Anaheim, Calif. Dr. Hall will present the current status of global development and the broad pharmaceutical indications for the company's innovative targeting technology platform that has enabled Epeius to develop Rexin-G(TM).

Epeius Biotechnologies Corporation Receives $400,000 Grant to Support Gene Therapy Trials for Pancreatic Cancer
Mon, 19 Jun 2006, 16:07:00 EDTEdited by Christopher L. Simmons
SAN MARINO, CA - June 19 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation announced today that the Company has been awarded a $400,000 grant by the Lazarex Cancer Foundation to expand and support ongoing cancer gene therapy clinical trials for advanced and metastatic pancreatic cancer.

Expanded Access Program for Rexin-G Provides Genetic Medicine to Cancer Patients, First Revenues for Epeius Biotechnologies
Fri, 07 Apr 2006, 15:40:00 EDTEdited by Christopher Laird Simmons
SAN MARINO, CA - Apr. 7 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation announced today that the Philippine Bureau of Food and Drugs (BFAD) has approved an Expanded Access Program for Rexin-G(TM), the lead product of Epeius Biotechnologies, developed for the treatment of metastatic cancer. Following the landmark approval of Rexin-G(TM) for the treatment of all solid tumors, the Expanded Access Program extends the clinical applications of the world's first targeted genetic medicine to many more cancer patients and enables Epeius Biotechnologies to recoup some of the costs of its ongoing clinical trials in Manila.

How to Support a Healthy Immune System During a Flu Pandemic
Tue, 10 Jan 2006, 11:09:00 EDTEdited by Carly Zander
CALGARY, AB - Jan. 10 (SEND2PRESS NEWSWIRE) -- A global flu pandemic with up to a billion fatalities is coming and humanity is quite unprepared. If vaccines aren't available, what will governments do to keep their citizens alive and healthy so the world economy does not crash? Hyperimmune Egg, the Super Egg, is a food supplement that can 'help the body achieve a balanced immune system' says Dr. Verna Mackey, CEO of Baby Boomer Productions.

Head Lice for the Holidays: A Gift that Keeps on Giving!
Mon, 12 Dec 2005, 15:06:00 EDTEdited by Carly Zander
JAMESVILLE, VA - Dec. 12 (SEND2PRESS NEWSWIRE) -- When family and friends get together for the holidays, the kids may come home with an unexpected gift, warn the head lice experts at Dermedics Laboratories, Jamesville, VA. And this is one gift you can't just return.

Ionic Silver Complex Designed for Use in Humans Receives U.S. Patent
Tue, 29 Nov 2005, 12:09:00 EDTEdited by Christopher Simmons
FORT LAUDERDALE, FL - Nov. 29 (SEND2PRESS NEWSWIRE) -- Invision International Health Solutions, Inc., a pioneer in the field of ionic silver use in humans, recently announced the issuance of a U.S. Patent on its 'Ionic Silver Complex' technology.

Heading Off Head Lice
Mon, 29 Aug 2005, 20:34:00 EDTEdited by Christopher Simmons
JAMESVILLE, VA - August 29 (SEND2PRESS NEWSWIRE) -- A new homeopathic shampoo from Dermedics Laboratories helps stop the spread of head lice, saves kids embarrassment and reduces exposure to toxins. To a child, back to school means a new backpack, a new teacher, and new friends. For parents, it may also mean a new problem: head lice! Getting a note from the teacher warning that head lice are rampant in your child's class - or worse, not getting a note but having your child come home scratching furiously - can be the start of a parental nightmare.

Breakthrough New Ergonomic Hand Sanitizer to be Introduced to Nation's Top Hospital Infection Fighters
Thu, 07 Apr 2005, 15:42:00 EDTEdited by Christopher Simmons
SANTA BARBARA, Calif. -- (SEND2PRESS NEWSWIRE) -- The nation's top hospital infection fighters will be getting a look at a new breakthrough ergonomic hand sanitizer that holds the promise of preventing 20,000 to 50,000 U.S. deaths each year. Sprixx is an alcohol hand sanitizer dispenser that you wear, use on-the-go, and is ergonomically designed to become a second-nature habit in use.

Rexin-G, the World's First Tumor-Targeted Gene Delivery Vector Used in Phase I Clinical Trial
Wed, 06 Apr 2005, 12:05:00 EDTEdited by Carly Zander
LOS ANGELES, Calif. -- (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corp. announced today that a Phase I clinical trial has opened in New York to test the safety and efficacy of Rexin-G, the leading tumor-targeted gene delivery system (vector) developed for the treatment of metastatic colon and pancreatic cancer.

Novel Patented Technology Enables Low Cost, Instant Ultraviolet Disinfection for Home and Personal Care Products
Mon, 14 Feb 2005, 14:17:00 EDTEdited by Christopher Laird Simmons
BOSTON, MA /Send2Press Newswire/ -- Ultraviolet disinfection technology developed for hospital-use now available for a number of home and personal care products such as toothbrushes, pacifiers, drinking cups, knives, cutting boards, etc. reports UVSolutions, LLC (www.uvs-ultraclean.com).

<< prev next >>

   Subscribe to Send2Press
News Channels via RSS:

Subscribe to this news category:
Drugs and Pharmaceuticals Feed

Subscribe to all news:
 Subscribe in a reader



Send2Press®
PR News Channels

Business News 
 
 U.S. and World Newswire
 Advertising and Marketing
 Aerospace and Aviation
 Agriculture and Farming
 Auction and Online Auctions
 Auto and Motorsports
 Banking and Finance
 Beauty Products
 Boating, Marine and Maritime
 Business
 Alliances and Partnerships 
 Awards and Honors 
 Earning Announcements 
 Funding and Investment 
 Government Procurement 
 International Business 
 Investment Services 
 Management Changes 
 Mergers and Acquisitions 
 New Locations and Growth 
 Patent and Trademark 
 Product Launches 
 Public Companies 
 Reports and Studies 
 Retail and Franchise 
 Communication Arts
 Fine Art and Artists 
 Graphic and Web Design 
 Journalism and Writing 
 Photography 
 Printing and Packaging 
 Computing
 Biometrics and Bioware 
 Events and Shows 
 Hardware and Peripherals 
 LBS and GPS Applications 
 Mobile Computing and PDA 
 Networks and Encryption 
 Software 
 Support and Warranties 
 VAR and IT Consulting 
 Construction and Building
 Architecture 
 Building Products 
 Building Projects 
 Business Services 
 Interior Design and Furniture 
 Corporate Social Responsibility - CSR
 Defense and Military
 Education and Schools
 Electronics
 Employment, HR and Outsourcing
 Energy, Oil and Gas
 Entertainment
 Acting and Modeling 
 Books and Publishing 
 Consumer Electronics and Gadgets 
 Fantasy Sports and Trivia 
 Fashion 
 Industry Services 
 Movies and Film Making 
 Music and Recording Industry 
 Offbeat 
 Online Publications and eZines 
 Performers and Parties 
 Podcasting 
 Pop Culture and Cool Stuff 
 Radio and Internet Radio 
 Television 
 Theater and Live Events 
 Video and DVD 
 Video Games and Software 
 Environment and Ecology
 Facilities and Building Maintenance
 Family, Parenting and Children
 Firearms and Airguns
 Food and Beverages
 General Editorial
 African American Interests 
 Brides and Weddings 
 Free Speech 
 Holidays and Seasons 
 Holistic and Spiritual 
 Latino Interests 
 Men's Interests 
 Native American Interests 
 Opinion and Commentary 
 Senior Citizen Interests 
 Women's Interests 
 Global Aid and Relief
 Government
 Awards and Events 
 Ballots, Bills and Laws 
 Economic Development 
 Elections and Politics 
 Local and Regional Govt. 
 Protests and Marches 
 Green Business
 Health, Diet and Fitness
 Home and Garden
 HVAC Heating and Cooling
 Insurance
 Internet and Websites
 Blogs and Forums 
 Business and Social Networking 
 Directories and Portals 
 e-Commerce 
 e-Marketing 
 New Websites 
 Online Shopping Sites 
 Video, VOD and Streaming 
 Web Development and Outsourcing 
 Web Hosting and ISPs 
 Web Software and ASP 
 Jewelry and Diamond
 Legal and Law
 Manufacturing
 Medical
 Alternative Medicine 
 Biotechnology 
 Cosmetic Surgery 
 Dentistry 
 Devices and Research 
 Disabilities and 508 Compliance 
 Drug Rehabilitation 
 Drugs and Pharmaceuticals 
 Fertility and IVF 
 Hospitals and Nursing 
 Long Term Care 
 Medical and Health Products 
 Medical Business Services 
 Private Practice and Medical Groups 
 Surgery and Neurotechnology 
 Mining and Metals
 NonProfit and Charities
 Plastics and Composites
 Police, Fire and Rescue
 Real Estate
 Regional Events
 Religion and Churches
 Restaurant, Hotel and Hospitality
 Safety and Security Solutions
 Sciences
 Astronomy 
 Nanotech 
 Sports and Activities
 Baseball 
 Basketball 
 Boxing and Weightlifting 
 Football 
 Golf 
 Martial Arts 
 Outdoors and Camping 
 Ski and Snow Sports 
 Soccer 
 Water Sports 
 Stamps, Coins and Collectables
 Taxes and Accounting
 Telecommunications and VoIP
 Theme Parks and Attractions
 Trade Shows, Fairs and Expos
 Transportation
 Travel and Tourism
 U.S. Companies
 Boating Industry Magazine 
 Charlie Allen Restorations 
 Jamaica Cottage Shop, Inc. 
 Media Mayhem Corporation 
 Sher Institutes for Reproductive Medicine 
 SolarReserve 
 WEWS NewsChannel 5 
 US and World History
 Veterinary and Pets
 
 U.S. State Newswires
 Alabama Business
 Alaska Business
 Arizona Business
 Phoenix Business 
 Sedona Business 
 California Business
 Hollywood Business 
 Los Angeles Business 
 Orange County Business 
 Sacramento Business 
 San Diego Business 
 San Francisco Business 
 San Jose Business 
 Santa Barbara Business 
 Silicon Valley Business 
 Colorado Business
 Boulder Business 
 Denver Business 
 Connecticut Business
 Florida Business
 Fort Lauderdale Business 
 Miami Business 
 Orlando Business 
 Tampa Business 
 Georgia Business
 Atlanta Business 
 Hawaii Business
 Idaho Business
 Illinois Business
 Chicago Business 
 Iowa Business
 Kansas Business
 Maryland Business
 Baltimore Business 
 Massachusetts Business
 Boston Business 
 Michigan Business
 Minnesota Business
 Missouri Business
 Nebraska Business
 Nevada Business
 Las Vegas Business 
 New Jersey Business
 New Mexico Business
 New York Business
 North Carolina Business
 Asheville Business 
 Ohio Business
 Oklahoma Business
 Oregon Business
 Pennsylvania Business
 Philadelphia Business 
 Puerto Rico Business
 South Carolina Business
 South Dakota Business
 Tennessee Business
 Texas Business
 Austin Business 
 Dallas Business 
 Houston Business 
 Utah Business
 Vermont Business
 Virginia Business
 Washington D.C. Business
 Washington State Business
 Kirkland Business 
 Seattle Business 
 West Virginia Business
 Wisconsin Business
 
 Video News Releases
 
 World Newswires
 Brazil Business
 Canada Business
 Ontario Canada Business 
 Vancouver Canada Business 
 Germany Business
 Spain Business
 United Kingdom

American Entertainment News and U.S. Business Newswire Headlines
Latest Headlines
U.S. and World Newswire
Millions of Americans Face $100,000-Plus Annual Hit for College and Long-Term-Care Combo
Podclass Announced as Recipient of fbFund for Application Built on Facebook(R) Platform
Renewable Energy Division Created at S+H Construction
New Devices Move Internet Videos Off PCs and Into Homes, Changing TV Forever, says Insight Research
Iglesias Nights - An Evening of Salsa Dancing and Latin Culture in Los Angeles - Giving Back to the Community with a Message of Hope and Success
Power Sports Factory, Inc. Engages American Financial Strategies to Promote Its Line of High Quality, Fuel Efficient, Premium Motorbikes
Get Green with Leader Phone(R) Web 2.0 Audio Conferencing
STG Media Corp and STG Interactive Help Launch Innovative Electro-Magnetic Pain Product in Canada
Mentoring Success Group Launches 'We Mentor Success' Events for Small Businesses
Paramito Global Holdings Announces Investment Activities
Telecom Training For Government Will Stretch Tax Dollars
CareTools Announces iChart Available on Apple App Store
ClusterSeven Releases New Version of its Spreadsheet Monitoring and Control Software
WhiteFlash.com Reaches Big 'O' Status in July
S+H Construction Announces Renewable Energy Division
Red Canyon Pictures Announce a Sneak Peek of Film 'Red Canyon' at HBO Presents: NYLIFF
World's Greatest Endurance Man Attempts Record Breaking Feats in New York City
LTC Financial Partners Named as Long Term Care Insurance Source by Kiplinger's 2nd Year in a Row
Paradigm Multimedia Technology Changes the Rules for Health Care TV Systems
Online Event Registration Equals Success for Event Marketing
PreViser Corporation Appoints Director of Medical Technology to Expand Further into Medicine
MMC Creates Unique Opportunities for Advertisers to Reach Horror Enthusiast
The National Urban and Community Forestry Advisory Council (NUCFAC) Hosts Public Forum on A Comprehensive Look at Tropical Forestry
Popular Orthopedics Medical Handbook Now Available in Portuguese
E-Cap from JAF Industries Can Save Homeowners Thousands of Dollars on a $10 Purchase
Electronic Medical Records Are No Longer Limited to Physicians with Deep Pockets
JBL Innovations Introduces $3.00 Contraption That Makes It Possible to See Picture Placement Without Hammering Nails
CheapOair and Hotels.com Sign Preferred Partnership
Top Ten Wildlife Safaris Worldwide
New Novel Portrays How a Woman Escapes an Abusive Marriage in Saudi Arabia and Undermines Islam
Forget Video Games: Learn to Fly a Real Airplane - On Line!
Artromick Automation Products Group Selects Katz Marketing Solutions for Brand Innovation Marketing
Eularis Analyzes Most Effective Generics Defense Strategies with New Pharmaceutical Industry Report
Publishers Newswire Announced Today its Latest List of Books to Bookmark
China Sage Consultants is Logical First Step to Doing Business in China
Jim 'Catfish' Hunter Foundation and The ALS Association Announce Opening of ALS Clinic at Pitt County Memorial Hospital in September
M2SYS Technology Selected by ZOLL Data Systems to Integrate Fingerprint Software
Foothills Community Partnership Fund Established in Collaboration with the Community Foundation of Calhoun County
Affinity Healthcare LLC Launches Travel Medicine Services
FDA Grants Epeius Biotechnologies' Rexin-G A Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
U.S. State Newswires
Millions of Americans Face $100,000-Plus Annual Hit for College and Long-Term-Care Combo
Podclass Announced as Recipient of fbFund for Application Built on Facebook(R) Platform
Renewable Energy Division Created at S+H Construction
New Devices Move Internet Videos Off PCs and Into Homes, Changing TV Forever, says Insight Research
Iglesias Nights - An Evening of Salsa Dancing and Latin Culture in Los Angeles - Giving Back to the Community with a Message of Hope and Success
Power Sports Factory, Inc. Engages American Financial Strategies to Promote Its Line of High Quality, Fuel Efficient, Premium Motorbikes
Get Green with Leader Phone(R) Web 2.0 Audio Conferencing
STG Media Corp and STG Interactive Help Launch Innovative Electro-Magnetic Pain Product in Canada
Mentoring Success Group Launches 'We Mentor Success' Events for Small Businesses
Paramito Global Holdings Announces Investment Activities
Telecom Training For Government Will Stretch Tax Dollars
CareTools Announces iChart Available on Apple App Store
ClusterSeven Releases New Version of its Spreadsheet Monitoring and Control Software
WhiteFlash.com Reaches Big 'O' Status in July
S+H Construction Announces Renewable Energy Division
Red Canyon Pictures Announce a Sneak Peek of Film 'Red Canyon' at HBO Presents: NYLIFF
World's Greatest Endurance Man Attempts Record Breaking Feats in New York City
LTC Financial Partners Named as Long Term Care Insurance Source by Kiplinger's 2nd Year in a Row
Paradigm Multimedia Technology Changes the Rules for Health Care TV Systems
PreViser Corporation Appoints Director of Medical Technology to Expand Further into Medicine
MMC Creates Unique Opportunities for Advertisers to Reach Horror Enthusiast
The National Urban and Community Forestry Advisory Council (NUCFAC) Hosts Public Forum on A Comprehensive Look at Tropical Forestry
Popular Orthopedics Medical Handbook Now Available in Portuguese
E-Cap from JAF Industries Can Save Homeowners Thousands of Dollars on a $10 Purchase
Electronic Medical Records Are No Longer Limited to Physicians with Deep Pockets
JBL Innovations Introduces $3.00 Contraption That Makes It Possible to See Picture Placement Without Hammering Nails
CheapOair and Hotels.com Sign Preferred Partnership
Top Ten Wildlife Safaris Worldwide
New Novel Portrays How a Woman Escapes an Abusive Marriage in Saudi Arabia and Undermines Islam
Forget Video Games: Learn to Fly a Real Airplane - On Line!
Artromick Automation Products Group Selects Katz Marketing Solutions for Brand Innovation Marketing
Eularis Analyzes Most Effective Generics Defense Strategies with New Pharmaceutical Industry Report
Publishers Newswire Announced Today its Latest List of Books to Bookmark
China Sage Consultants is Logical First Step to Doing Business in China
Jim 'Catfish' Hunter Foundation and The ALS Association Announce Opening of ALS Clinic at Pitt County Memorial Hospital in September
M2SYS Technology Selected by ZOLL Data Systems to Integrate Fingerprint Software
Foothills Community Partnership Fund Established in Collaboration with the Community Foundation of Calhoun County
Affinity Healthcare LLC Launches Travel Medicine Services
FDA Grants Epeius Biotechnologies' Rexin-G A Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
A Ghost Worked on the New Instrumental Album by The G-Man
Video News Releases
Podclass Announced as Recipient of fbFund for Application Built on Facebook(R) Platform
E-Cap from JAF Industries Can Save Homeowners Thousands of Dollars on a $10 Purchase
A Ghost Worked on the New Instrumental Album by The G-Man
Ayurvedic Organic Jeans: Custom Clothing Company Makes Garments That Possess Medicinal Benefits
Museum of Robots in Second Life Announces Competition Winners at Event on July 19, 2008
Singles Dance Parties in Berkeley and Sacramento
ThinkBox Launches 'Showy Show!' - Breakthrough Children's Video Series
Videos Introduce Public to Long Term Care Advisors, a New Trend Leading Agency Begins Using Media to Build Trust in Agents
Success for Crystal Meth Drug Addict on YouTube
Ballantine Corporation Releases 2008 Direct Mail Control Report
Career Launch Package is Grand Prize at LAMN Jam '08 - Urban and Rock Artists Invited to Perform
'Easy' is the Best Word to Describe This New Family Fun Sport Product - The Wind Chaser(R) Land Sailor
Nurse Gives Dragons A Shot
San Francisco Singles Dance Party and Mixer at Golden Gate Yacht Club
Retail Closeout Mall Helps Shoppers Give Themselves a Raise